Skip to main content
. 2023 Oct 31;14:313. doi: 10.1186/s13287-023-03545-8

Table 2.

Patient’s characteristics

Case Number Age Gender FEV1 (%) BMI Pleural adhesions PAL Score (grade) Bronchodilatation treatment ASA score Diagnosis Histological type Pathological stage
1 62 Male 66.9 22.26 Yes 2.5 (C) Yes III NSCLC Large-cell neuroendocrine carcinoma IIB
2 70 Male 71.9 25.45 No 2.5 (C) No III NSCLC Adenocarcinoma IA2
3 55 Female 79.9 17.90 No 3.5 (D) Yes II NSCLC Adenocarcinoma IIA
4 69 Male 78.6 23.68 Yes 3.5 (D) No III NSCLC Adenocarcinoma IA2
5 64 Male 58.6 18.75 Yes 4.5 (D) No III NSCLC Adenocarcinoma IA3
6 68 Male 63.4 25.00 Yes 3.5 (D) Yes III Pulmonary nodule Hamartoma
7 64 Male 34.9 17.44 No 3.5 (D) Yes II Pulmonary emphysema Bullous emphysema
8 73 Male 42.5 17.48 No 4.5 (D) Yes II Pulmonary emphysema Bullous emphysema

FEV1 Forced expiratory volume in the first second, BMI body mass index, PAL prolonged air leak, ASA score American Society of Anaesthesiologist score, NSCLC non-small-cell lung cancer